Management of coexistent neurogenic orthostatic hypotension and supine hypertension.
作者信息
Cannom David S
机构信息
Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.
出版信息
J Clin Hypertens (Greenwich). 2019 Nov;21(11):1732-1734. doi: 10.1111/jch.13699. Epub 2019 Oct 10.
Abstract
摘要
相似文献
1
Management of coexistent neurogenic orthostatic hypotension and supine hypertension.并存的神经源性直立性低血压和卧位高血压的管理。
J Clin Hypertens (Greenwich). 2019 Nov;21(11):1732-1734. doi: 10.1111/jch.13699. Epub 2019 Oct 10.
2
Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials.体位性低血压患者使用屈昔多巴和米多君的立位和卧位血压结局：随机试验的贝叶斯荟萃分析和混合治疗比较。
Ann Pharmacother. 2018 Dec;52(12):1182-1194. doi: 10.1177/1060028018786954. Epub 2018 Jul 4.
3
Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease.调整屈昔多巴治疗帕金森病患者神经源性直立性低血压
Clin Auton Res. 2017 Jul;27(Suppl 1):17-19. doi: 10.1007/s10286-017-0431-9. Epub 2017 Jun 19.
4
Diagnosing and treating neurogenic orthostatic hypotension in primary care.在初级保健中诊断和治疗神经源性直立性低血压
Postgrad Med. 2015;127(7):702-15. doi: 10.1080/00325481.2015.1050340. Epub 2015 May 27.
5
Defining successful treatment of neurogenic orthostatic hypotension with droxidopa in a patient with multiple system atrophy.在一名多系统萎缩患者中定义用屈昔多巴成功治疗神经源性直立性低血压。
Clin Auton Res. 2017 Jul;27(Suppl 1):21-23. doi: 10.1007/s10286-017-0432-8. Epub 2017 Jun 19.
6
Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension.滴定屈昔多巴以最大化帕金森病合并神经源性直立性低血压患者的症状获益。
Clin Auton Res. 2017 Jul;27(Suppl 1):15-16. doi: 10.1007/s10286-017-0430-x. Epub 2017 Jul 11.
7
Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa.帕金森病中的神经源性直立性低血压：评估、管理及屈昔多巴的新作用
Vasc Health Risk Manag. 2014 Apr 3;10:169-76. doi: 10.2147/VHRM.S53983. eCollection 2014.
8
Supine hypertension during general anesthesia in a patient taking midodrine.
Anesth Analg. 2002 Nov;95(5):1196-7, table of contents. doi: 10.1097/00000539-200211000-00014.
9
Orthostatic hypotension: pathophysiology, assessment, treatment and the paradox of supine hypertension.直立性低血压：病理生理学、评估、治疗及仰卧位高血压悖论
Intern Med J. 2017 Apr;47(4):370-379. doi: 10.1111/imj.13171.
10
New developments in the management of neurogenic orthostatic hypotension.神经源性直立性低血压管理的新进展。
Curr Cardiol Rep. 2014 Nov;16(11):542. doi: 10.1007/s11886-014-0542-z.
引用本文的文献
1
Hypertension depresses arterial baroreflex control of both heart rate and cardiac output during rest, exercise, and metaboreflex activation.高血压在休息、运动和代谢反射激活期间抑制动脉压力感受器反射对心率和心输出量的控制。
Am J Physiol Regul Integr Comp Physiol. 2022 Nov 1;323(5):R720-R727. doi: 10.1152/ajpregu.00093.2022. Epub 2022 Sep 19.
本文引用的文献
1
Six-Month Use of Droxidopa for Neurogenic Orthostatic Hypotension.使用屈昔多巴治疗神经源性直立性低血压六个月
Mov Disord Clin Pract. 2019 Mar 7;6(3):235-242. doi: 10.1002/mdc3.12726. eCollection 2019 Mar.
2
Management of supine hypertension in patients with neurogenic orthostatic hypotension: scientific statement of the American Autonomic Society, European Federation of Autonomic Societies, and the European Society of Hypertension.神经源性直立性低血压患者仰卧位高血压的管理：美国自主神经科学学会、欧洲自主神经科学学会和欧洲高血压学会的科学声明。
J Hypertens. 2019 Aug;37(8):1541-1546. doi: 10.1097/HJH.0000000000002078.
3
Characterization of the symptoms of neurogenic orthostatic hypotension and their impact from a survey of patients and caregivers.通过对患者和护理人员的调查来描述神经源性直立性低血压的症状及其影响。
BMC Neurol. 2018 Aug 25;18(1):125. doi: 10.1186/s12883-018-1129-x.
4
Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials.体位性低血压患者使用屈昔多巴和米多君的立位和卧位血压结局：随机试验的贝叶斯荟萃分析和混合治疗比较。
Ann Pharmacother. 2018 Dec;52(12):1182-1194. doi: 10.1177/1060028018786954. Epub 2018 Jul 4.
5
Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS) : Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH).美国自主神经科学学会（AAS）和欧洲自主神经科学学会联合会（EFAS）关于心血管自主神经衰竭中神经源性仰卧位高血压定义的共识声明：得到欧洲神经病学学会（EAN）和欧洲高血压学会（ESH）的认可。
Clin Auton Res. 2018 Aug;28(4):355-362. doi: 10.1007/s10286-018-0529-8. Epub 2018 May 15.
6
Autonomic dysfunction in Parkinson's disease: A prospective cohort study.帕金森病自主神经功能障碍：一项前瞻性队列研究。
Mov Disord. 2018 Mar;33(3):391-397. doi: 10.1002/mds.27268. Epub 2017 Dec 26.
7
Orthostatic hypotension in Parkinson disease: Impact on health care utilization.帕金森病中的直立性低血压：对医疗保健利用的影响。
Parkinsonism Relat Disord. 2018 Feb;47:45-49. doi: 10.1016/j.parkreldis.2017.11.344. Epub 2017 Nov 28.
8
Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension.用于神经源性直立性低血压的屈昔多巴试验的综合分析。
BMC Neurol. 2017 May 12;17(1):90. doi: 10.1186/s12883-017-0867-5.
9
Fall-related healthcare use and costs in neurogenic orthostatic hypotension with Parkinson's disease.帕金森病合并神经源性直立性低血压患者与跌倒相关的医疗保健使用及费用
J Med Econ. 2017 May;20(5):525-532. doi: 10.1080/13696998.2017.1284668. Epub 2017 Feb 6.
10
The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension.一个共识小组关于神经源性直立性低血压及相关卧位高血压的筛查、诊断和治疗的建议。
J Neurol. 2017 Aug;264(8):1567-1582. doi: 10.1007/s00415-016-8375-x. Epub 2017 Jan 3.
Zotero 插件